Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urinary kynurenine as a biomarker for Parkinson’s disease
Jia-he Bai, Ya-li Zheng, Yong-Peng Yu
Neurological Sciences (2020) Vol. 42, Iss. 2, pp. 697-703
Closed Access | Times Cited: 23

Showing 23 citing articles:

Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
Nóra Török, Masaru Tanaka, László Vécsei
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9338-9338
Open Access | Times Cited: 109
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders
Dan Li, Shuang Yu, Yu Long, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 66
Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
Yinrou Huang, Mengke Zhao, Xuemei Chen, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 858-858
Open Access | Times Cited: 65
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis
Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Liquid Biopsy in Neurological Diseases
Sunny Malhotra, Mari Carmen Martín Miras, Agustín Pappolla, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1911-1911
Open Access | Times Cited: 29
Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease
Ping Chen, Xiaofei Geng
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 28
Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
Nóra Török, Masaru Tanaka, László Vécsei
(2020)
Open Access | Times Cited: 53
Biomarkers: Role and Scope in Neurological Disorders
Vivek Sharma, Thakur Gurjeet Singh, Vineet Mehta, et al.
Neurochemical Research (2023) Vol. 48, Iss. 7, pp. 2029-2058
Closed Access | Times Cited: 17
Biomarkers of Parkinson’s Disease: From Basic Research to Clinical Practice
Zi-Lu Ma, Zhangli Wang, Feiyue Zhang, et al.
Aging and Disease (2023)
Open Access | Times Cited: 16
Urinary Biomarkers for Neurodegenerative Diseases
Wongi Seol, Hye‐Jung Kim, Ilhong Son
Experimental Neurobiology (2020) Vol. 29, Iss. 5, pp. 325-333
Open Access | Times Cited: 36
Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease
Haoran Peng, Siyuan Chen, Shaopu Wu, et al.
Journal of the Neurological Sciences (2023) Vol. 451, pp. 120730-120730
Open Access | Times Cited: 12
Urinary based biomarkers identification and genetic profiling in Parkinson’s disease: a systematic review of metabolomic studies
Neetu Rani Dhiman, S. K. Singh, Royana Singh, et al.
Frontiers in Bioinformatics (2025) Vol. 5
Open Access
Research Progress of Tryptophan-Related Metabolites in Parkinson’s Disease
利丽 徐
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 3455-3464
Closed Access
Liquid Biopsy in Neurological Diseases
Sunny Malhotra, Mari Carmen Martín Miras, Agustín Pappolla, et al.
(2023)
Open Access | Times Cited: 7
Alterations in the Blood Kynurenine Pathway Following Long-Term PM2.5 and PM10 Exposure: A Cross-Sectional Study
Churdsak Jaikang, Giatgong Konguthaithip, Yutti Amornlertwatana, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1947-1947
Open Access | Times Cited: 2
Serum neurotransmitter analysis of motor and non-motor symptoms in Parkinson’s patients
Yichun Fan, Wenping Yang, Weilan Wu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
Pursuing Multiple Biomarkers for Early Idiopathic Parkinson’s Disease Diagnosis
Yareth Gopar-Cuevas, Ana Patricia Duarte-Jurado, Rosa Diaz-Perez, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 11, pp. 5517-5532
Closed Access | Times Cited: 8
Diagnosis of Parkinson's disease by investigating the inhibitory effect of serum components on P450 inhibition assay
Kohei Ihara, Ami Oguro, Hiromasa Imaishi
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 5
The Involvement of Kynurenine Pathway in Neurodegenerative Diseases
Laís Bhering Martins, Ana Letícia Malheiros Silveira, Antônio Lúcio Teixeira
Current Neuropharmacology (2022) Vol. 21, Iss. 2, pp. 260-272
Open Access | Times Cited: 5
Folic Acid and Vitamin B12 Prevent Deleterious Effects of Rotenone on Object Novelty Recognition Memory and Kynu Expression in an Animal Model of Parkinson’s Disease
Gabriela Canalli Kretzschmar, Adriano Targa, Sheila Coelho Soares-Lima, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2397-2397
Open Access | Times Cited: 4
Normative Data on Serum and Plasma Tryptophan and Kynurenine Concentrations from 8089 Individuals Across 120 Studies: A Systematic Review and Meta-Analysis
Najwa‐Joelle Metri, Ali S Butt, Ava Murali, et al.
International Journal of Tryptophan Research (2023) Vol. 16
Open Access | Times Cited: 1
Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
Emma D. Frost, Shuyan Shi, Vishnu Byroju, et al.
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1163-1163
Open Access
Development of a new assay system for bladder cancer using interactions between cytochromes P450 and serum
Hiroki Kuwada, Kohei Ihara, Hiromasa Imaishi
Drug Metabolism and Pharmacokinetics (2022) Vol. 47, pp. 100472-100472
Open Access | Times Cited: 2
Page 1

Scroll to top